Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a small update to page metadata/UI without changes to the trial details.
    Difference
    0.0%
    Check dated 2026-08-29T19:26:39.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, reflecting a minor adjustment to the study record metadata.
    Difference
    0.0%
    Check dated 2026-08-08T18:44:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4 to reflect a new version of the page.
    Difference
    0.0%
    Check dated 2026-07-25T10:29:11.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the page's content or formatting since the last version.
    Difference
    0.0%
    Check dated 2026-07-03T22:36:44.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now displays an updated software revision tag, changing from v3.6.0 to v3.6.2. This reflects a platform update rather than a change to the study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-06-27T01:03:39.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    The page now explicitly indicates that recruitment is closed and adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study). A formatting update replaces the Interventions heading from 'Intervention / Treatment' to 'Intervention/Treatment' and updates the revision tag from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T13:38:16.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.